The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators
摘要:
Free fatty acid receptor 2 (FFA2) is a G-protein coupled receptor for which only short-chain fatty acids (SCFAs) have been reported as endogenous ligands. We describe the discovery and optimization of phenylacetamides as allosteric agonists of FFA2. These novel ligands can suppress adipocyte lipolysis in vitro and reduce plasma FFA levels in vivo, suggesting that these allosteric modulators can serve as pharmacological tools for exploring the potential function of FFA2 in various disease conditions. (C) 2009 Elsevier Ltd. All rights reserved.
La composición insecticida contiene como ingredientes activos (a) fósforotioato de O,O-dimetil O-4-nitro-m-tolilo; y (b) α-(4-clorofenil)-3-metil-isovalerato de α-ciano-3-fenoxibencilo, sus estereoisómeros aislados y mezclas de los mismos, por ejemplo, (S)-α-(4-clorofenil)-3-metil-isovalerato de (S)-α-ciano-3-fenoxibencilo, en una relación en peso comprendida entre 50:1 y 1:1 [ingrediente a): ingrediente b)]. La composición puede utilizarse tal cual o mezclada con un vehículo apropiado, junto con, opcionalmente, aditivos y agentes auxiliares de formulación. Las composiciones y formulaciones mencionadas son especialmente adecuadas para controlar carcoma, polillas y termitas.
The first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators
Free fatty acid receptor 2 (FFA2) is a G-protein coupled receptor for which only short-chain fatty acids (SCFAs) have been reported as endogenous ligands. We describe the discovery and optimization of phenylacetamides as allosteric agonists of FFA2. These novel ligands can suppress adipocyte lipolysis in vitro and reduce plasma FFA levels in vivo, suggesting that these allosteric modulators can serve as pharmacological tools for exploring the potential function of FFA2 in various disease conditions. (C) 2009 Elsevier Ltd. All rights reserved.